Table 2.
Risk of the most represented lymphoma subtypes associated with AhR activation. Risks for the group of B-cell Lymphoma (all subtypes), and for all lymphomas combined are also shown
| N | AhR + (N, %) | OR (95% CI) | |
|---|---|---|---|
| Controls | 357 | 63, 17.6 | Ref |
| Diffuse large B-cell Lymphoma | 108 | 15, 13.9 | 0.79 (0.43-1.46) |
| Follicular Lymphoma | 85 | 20, 23.5 | 1.56 (0.87-2.80) |
| Chronic Lymphocytic Leukaemia | 72 | 17, 23.6 | 1.56 (0.83-2.96) |
| Multiple Myeloma | 60 | 13, 21.7 | 1.37 (0.68-2.76) |
| Hodgkin Lymphoma | 94 | 19, 20.2 | 1.12 (0.59-2.13) |
| B-cell Lymphoma (all subtypes) | 405 | 82, 20.2 | 1.23 (0.84-1.78) |
| Lymphoma (all subtypes) | 572 | 114, 19.9 | 1.21 (0.86-1.70) |